11-108345819-G-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000051.4(ATM):c.8495G>T(p.Arg2832Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2832S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000051.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATM | NM_000051.4 | MANE Select | c.8495G>T | p.Arg2832Leu | missense | Exon 58 of 63 | NP_000042.3 | ||
| ATM | NM_001351834.2 | c.8495G>T | p.Arg2832Leu | missense | Exon 59 of 64 | NP_001338763.1 | |||
| C11orf65 | NM_001330368.2 | c.641-36748C>A | intron | N/A | NP_001317297.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATM | ENST00000675843.1 | MANE Select | c.8495G>T | p.Arg2832Leu | missense | Exon 58 of 63 | ENSP00000501606.1 | ||
| ATM | ENST00000452508.7 | TSL:1 | c.8495G>T | p.Arg2832Leu | missense | Exon 59 of 64 | ENSP00000388058.2 | ||
| ATM | ENST00000527805.6 | TSL:1 | n.*3559G>T | non_coding_transcript_exon | Exon 56 of 61 | ENSP00000435747.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Ataxia-telangiectasia syndrome Pathogenic:2
This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 2832 of the ATM protein (p.Arg2832Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with ataxia-telangiectasia (Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 430406). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This variant disrupts the p.Arg2832 amino acid residue in ATM. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9443866, 10817650, 10873394, 12552559, 18634022). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
not provided Pathogenic:2
This variant has not been reported in large, multi-ethnic general populations. (http://gnomad.broadinstitute.org) This variant has been identified in at least one individual with clinical features associated with this gene. Multiple missense variants at this codon, including at least one considered to be pathogenic or likely pathogenic, have been reported in individuals with clinical features associated with this gene, suggesting this variant may also cause disease. Polyphen and MutationTaster predict this amino acid change may be damaging to the protein.
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in a patient with chronic lymphocytic leukemia; however, it is unclear if the variant was germline or somatic (Landau et al., 2015); This variant is associated with the following publications: (PMID: 23532176, 26466571, 36999792)
Hereditary cancer-predisposing syndrome Pathogenic:2
This missense variant replaces arginine with leucine at codon 2832 of the ATM protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individuals affected with ataxia-telangiectasia (PMID: 37438524, ClinVar: SCV000622825.3, SCV002675381.2). Two different variant affecting the same codon, c.8494C>T (p.Arg2832Cys) and c.8495G>C (p.Arg2832Pro), are considered to be disease-causing (ClinVar variation IDs: 127459, 429065), suggesting that arginine at this position is important for the protein function. This variant, c.8495G>T (p.Arg2832Leu), has not been identified in the general population by the Genome Aggregation Database (gnomAD). Based on the available evidence, this variant is classified as Likely Pathogenic.
The p.R2832L variant (also known as c.8495G>T), located in coding exon 57 of the ATM gene, results from a G to T substitution at nucleotide position 8495. The arginine at codon 2832 is replaced by leucine, an amino acid with dissimilar properties. This alteration has been reported in conjunction with another pathogenic ATM mutation in individuals with features of ataxia telangiectasia (AT) (correspondence with external clinical laboratories). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the majority of available evidence to date, this variant is likely to be pathogenic.
Familial cancer of breast Pathogenic:1
This variant is considered likely pathogenic. This variant has been reported in multiple individuals with clinical features of gene-specific disease [PMID: 37438524, Myriad internal data]. Functional studies indicate this variant impacts protein function [PMID: 18634022, 21792198]. This variant is expected to disrupt protein structure [Myriad internal data].
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at